From the Editor:
April 3, 2018
Dear Colleagues and Members of SCVP
The responses to the 2018 survey of the membership conducted by our long range planning chair, Dr. John Veinot, are now posted at the Members Only section of the SCVP web site. I am gratified by the favorable comments about our society's journal, Cardiovascular Pathology (CVP). I want to respond to some of the questions and comments.
We endeavor to publish a mix of original research, review articles, consensus documents and case reports that focus on the pathology and pathogenesis of cardiovascular disease. In 2017, we received 249 manuscripts, and our overall acceptance rate is 24.5%. We reject out of hand manuscripts which we judge to be outside of the scope of the journal and only send out for review manuscripts which we deem to fit broadly within the scope of the journal. We have been selective with the case reports and images striving for interesting and novel findings. The original research we publish includes both experimental studies and studies based on humans.
The responses to the survey indicated an interest in more review articles and thematic issues. There also is an underlying thread of having the editor give priority to the publication of articles that resonate with the core interests of the membership of the society. We will continue to work on soliciting review articles and take under consideration thematic issues, although the latter are quite challenging to assemble. However, the most important way to enhance the relevance of CVP for the membership is for members, including members on the Editorial Board and others, to regularly submit your work for publication in the journal. An aspirational goal for the more active members is to submit one of your manuscripts to CVP every year or two. I urge you to contribute to this goal of manuscript submissions by members.
Another issue relates to our current practice of publishing both print and electronic editions of the journal. We have discussed the option of electronic only with our Elsevier publisher and the society leadership. Our contract with Elsevier establishes that members will receive both print and electronic access to the journal. Our discussions indicated that, given the size of our membership, there would be little savings to be had for individual members with an electronic only option. We concur with the view that there is merit to providing the members with print copies of the journal as tangible recognition of membership in the society.
Also we have been informed by our publisher, Jason Winkler, that Elsevier is undertaking a consolidation of its products and channels that deliver digital journal content. As a consequence, the website for Cardiovascular Pathology (cardiovascularpathology.com/) will be discontinued in the coming months. This is in tandem with an ongoing commitment to continued improvement and further enhancements to ScienceDirect, Elsevier's flagship platform of peer-reviewed scholarly literature. CVP www.sciencedirect.com/journal/cardiovascular-pathology), already has a presence on ScienceDirect. Our publisher is working with the digital team to ensure the custom content now available on the website is available on the Elseiver.com home page (www.journals.elsevier.com/cardiovascular-pathology/). He is also reviewing the journal presence on ScienceDirect to ensure all customization options applicable to the journal are being used to serve the benefit of the journal content and brand. Hopefully this will be a smooth transition.
I appreciate the continued interest and participation of members of SCVP in the activities of CVP. I continue to welcome your comments and suggestions.
L. Maximilian Buja, M.D.
Read previous editor pages in the Archives.